Skip to main content
Log in

Differenzialdiagnose der Hämaturie

Differential diagnosis of hematuria

  • CME Zertifizierte Fortbildung
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Hämaturie ist das Leitsymptom etlicher urologischer und nephrologischer Erkrankungen. Bei der Differenzialdiagnose wird zwischen schmerzhafter und schmerzloser und zwischen der mit bloßem Auge sichtbaren Makro- und der nicht sichtbaren Mikrohämaturie unterschieden. Als Grund für eine Hämaturie kommen prinzipiell renale (glomeruläre) und nicht renale (nicht glomeruläre) Ursachen in Frage. Um einerseits Frühsymptome maligner und relevanter gutartiger Erkrankungen nicht zu verpassen und um andererseits eine übermäßige Diagnostik zu vermeiden, ist ein differenziertes Vorgehen wichtig.

Abstract

Hematuria is the main symptom of many urological and nephrological diseases. In the differential diagnostics a distinction is made between painful and pain-free and between macrohematuria which is visible to the naked eye and microhematuria which is not visible. The reasons for hematuria are basically renal (glomerular) and non-renal (non-glomerular) causes. In order not to overlook early symptoms of malignant and relevant benign diseases and also to avoid excessive diagnostic tests, a differentiated approach is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Feldman A, Hsu C, Kurtz M, Cho K (2013) Etiology and evaluation of hematuria in adults. Wolters Kluwer Health, http://www.uptodate.com/contents/etiology-and-evaluation-of-hematuria-in-adults

  2. Jichlinski P (2010) Hämaturie. In: Hubert J (Hrsg) Urologische Fragen in der Grundversorgung. UNI-MED, Bremen, S 31–47

  3. Davis R, Jones JS, Barocas DA et al (2012) Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline. J Urol 188(6 Suppl):2473–2481

    Article  PubMed  Google Scholar 

  4. Anderson J, Fawcett D, Feehally J et al (2008) Joint consensus statement on the initial assessment of haematuria. BAUS/RA Guidelines 2008:1–5

  5. Roth S (1995) Hämaturiediagnostik und Erythrozytenmorphologie. In: Rathert P (Hrsg) Urinzytologie. Springer, Heidelberg, S 195–221

  6. Rockall AG, Newman-Sanders AP, al-Kutoubi MA, Vale JA (1997) Haematuria. Postgrad Med J 73:129–136

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Mariani AJ, Mariani MC, Macchioni C et al (1989) The significance of adult hematuria: 1,000 hematuria evaluations including a risk-benefit and cost-effectiveness analysis. J Urol 141:350–355

    CAS  PubMed  Google Scholar 

  8. Jones DJ, Langstaff RJ, Holt SD, Morgans BT (1988) The value of cystourethroscopy in the investigation of microscopic haematuria in adult males under 40 years. A prospective study of 100 patients. Br J Urol 62:541–545

    Article  CAS  PubMed  Google Scholar 

  9. Vester U, Hoyer PF (2001) Microsopic hematuria in childhood. Monatsschr Kinderheilkd 149:770–773

    Article  Google Scholar 

  10. Khadra MH, Pickard RS, Charlton M et al (2000) A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol 163:524–527

    Article  CAS  PubMed  Google Scholar 

  11. Foley SJ, Soloman LZ, Wedderburn AW et al (2000) A prospective study of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of finasteride. J Urol 163:496–498

    Article  CAS  PubMed  Google Scholar 

  12. Vasdev N, Kumar A, Veeratterapillay R, Thorpe A (2012) Hematuria secondary to benign prostatic hyperplasia: retrospective analysis of 166 men identified in a single one stop hematuria clinic. Curr Urol 6:146–149

    Article  PubMed Central  PubMed  Google Scholar 

  13. Satasivam P, Reeves F, Lin M et al (2012) The effect of oral anticoagulation on the prevalence and management of haematuria in a contemporary Australian patient cohort. BJU Int 110(Suppl 4):80–84

    Article  CAS  PubMed  Google Scholar 

  14. Massry SG, Glassock RJ (2001) Massry & Glassock’s Textbook of Nephrology, 4th edn. Lippincott Willians & Wilkins, Philadelphia

  15. Grossfeld GD, Litwin MS, Wolf JS Jr et al (2001) Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy – part II: patient evaluation, cytology, voided markers, imaging, cystoscopy, nephrology evaluation, and follow-up. Urology 57:604–610

    Article  CAS  PubMed  Google Scholar 

  16. Rodgers M, Nixon J, Hempel S et al (2006) Diagnostic tests and algorithms used in the investigation of haematuria: systematic reviews and economic evaluation. Health Technol Assess 10:iii–iv, xi-259

    CAS  Google Scholar 

  17. Mowatt G, N’Dow J, Vale L et al (2011) Photodynamic diagnosis of bladder cancer compared with white light cystoscopy: systematic review and meta-analysis. Int J Technol Assess Health Care 27:3–10

    Article  PubMed  Google Scholar 

  18. Choyke PL (2008) Radiologic evaluation of hematuria: guidelines from the American College of Radiology’s appropriateness criteria. Am Fam Physician 78:347–352

    PubMed  Google Scholar 

  19. Chow LC, Kwan SW, Olcott EW, Sommer G (2007) Split-bolus MDCT urography with synchronous nephrographic and excretory phase enhancement. AJR Am J Roentgenol 189:314–322

    Article  PubMed  Google Scholar 

  20. Patschan O, Horstmann M, Thomas C et al (2008) Diagnostic procedures in upper urinary tract urothelial carcinoma. Urologe A 47:1487–1496

    Article  CAS  PubMed  Google Scholar 

  21. Babjuk M, Burger M, Zigeuner R et al (2013) EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS). European Association of Urology, http://www.uroweb.org/gls/pdf/05_TaT1_Bladder_Cancer_LR.pdf

  22. Horstmann M (2012) Currently available urine-based tumour markers in the detection of new and recurrent urothelial bladder cancer. Nephro-Urol Mon 4:345–349

  23. Tombinski J (2013) Asymptomatische Mikrohämaturie: Wie viel Diagnostik ist notwendig? J Urol Urogynäkol 20:4

    Google Scholar 

  24. Loo RK, Lieberman SF, Slezak JM et al (2013) Stratifying risk of urinary tract malignant tumors in patients with asymptomatic microscopic hematuria. Mayo Clinic Proc 88:129–138

    Article  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. M. Horstmann, T. Franiel und M.O. Grimm geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Horstmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horstmann, M., Franiel, T. & Grimm, M. Differenzialdiagnose der Hämaturie. Urologe 53, 1215–1226 (2014). https://doi.org/10.1007/s00120-014-3506-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-014-3506-4

Schlüsselwörter

Keywords

Navigation